DK1495051T3 - Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler - Google Patents

Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler

Info

Publication number
DK1495051T3
DK1495051T3 DK03723513T DK03723513T DK1495051T3 DK 1495051 T3 DK1495051 T3 DK 1495051T3 DK 03723513 T DK03723513 T DK 03723513T DK 03723513 T DK03723513 T DK 03723513T DK 1495051 T3 DK1495051 T3 DK 1495051T3
Authority
DK
Denmark
Prior art keywords
fibrinogen
fibrin
properties
lmw
hmw
Prior art date
Application number
DK03723513T
Other languages
Danish (da)
English (en)
Inventor
Maat Monica Petronella Maria De
Pieter Koolwijk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of DK1495051T3 publication Critical patent/DK1495051T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/046Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03723513T 2002-04-18 2003-04-07 Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler DK1495051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1020426A NL1020426C2 (nl) 2002-04-18 2002-04-18 Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.
PCT/NL2003/000293 WO2003087160A1 (en) 2002-04-18 2003-04-07 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells

Publications (1)

Publication Number Publication Date
DK1495051T3 true DK1495051T3 (da) 2008-11-10

Family

ID=29244993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03723513T DK1495051T3 (da) 2002-04-18 2003-04-07 Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler

Country Status (10)

Country Link
US (2) US7867519B2 (https=)
EP (1) EP1495051B1 (https=)
JP (3) JP5083928B2 (https=)
AT (1) ATE403679T1 (https=)
AU (1) AU2003230455A1 (https=)
CA (1) CA2482893C (https=)
DE (1) DE60322687D1 (https=)
DK (1) DK1495051T3 (https=)
NL (1) NL1020426C2 (https=)
WO (1) WO2003087160A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514474C (en) 2003-01-30 2014-05-06 Avner Yayon Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
EP2106263B1 (en) 2007-01-04 2016-12-21 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20110177524A1 (en) 2008-07-09 2011-07-21 Profibrix Bv Recombinant Fibrinogen
WO2011083154A1 (en) * 2010-01-08 2011-07-14 Profibrix Bv Dry powder fibrin sealant
ES2524886T3 (es) * 2010-01-08 2014-12-15 Profibrix Bv Preparados de fibrinógeno enriquecidos en fibrinógeno con una cadena alfa extendida
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
WO2017027378A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142581A3 (en) * 1990-11-27 2002-09-11 American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
CA2188647A1 (en) * 1994-05-02 1995-11-09 Stewart Anthony Cederholm-Williams Recombinant fibrin chains, fibrin and fibrin-homologs
ATE244584T1 (de) * 1995-01-16 2003-07-15 Baxter Int Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
AU4351000A (en) * 1999-04-15 2000-11-02 Research Foundation Of State University Of New York, The Cellular matrix system and use thereof
WO2000072852A1 (en) * 1999-06-01 2000-12-07 Bristol-Myers Squibb Company Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
JP2005538045A (ja) 2005-12-15
JP2010246543A (ja) 2010-11-04
CA2482893A1 (en) 2003-10-23
JP5395726B2 (ja) 2014-01-22
EP1495051B1 (en) 2008-08-06
JP2010195805A (ja) 2010-09-09
JP5248547B2 (ja) 2013-07-31
DE60322687D1 (de) 2008-09-18
WO2003087160A1 (en) 2003-10-23
US7867519B2 (en) 2011-01-11
CA2482893C (en) 2014-08-12
US20110071083A1 (en) 2011-03-24
JP5083928B2 (ja) 2012-11-28
US20050181972A1 (en) 2005-08-18
ATE403679T1 (de) 2008-08-15
AU2003230455A1 (en) 2003-10-27
NL1020426C2 (nl) 2003-10-21
EP1495051A1 (en) 2005-01-12

Similar Documents

Publication Publication Date Title
DK1495051T3 (da) Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler
ATE262356T1 (de) Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement
DK0625056T3 (da) Kompositmembraner til reguleret regenerering af væv
DK1635731T3 (da) Fremgangsmåde til forebyggelse af kirurgisk adhæsion
ATE265241T1 (de) Resorbierbare implantatmaterialien
ATE525100T1 (de) Poröse matrix
DE69231421D1 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
DE69231796D1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
MX167917B (es) Nuevos materiales y dispositivos quirurgicos
NO20035569L (no) Sarbandasje og metode for kontroll av livstruende blodning
GB2348426A (en) Enzyme-mediated modification of fibrin for tissue engineering
ATE418301T1 (de) Materialien zur knochen- und sehnentransplantation
NO912635L (no) Deformerbar kirurgisk anordning.
DK1316322T3 (da) Poröse vævsstilladser til opheling og regeneration af hudvæv
DE69433920D1 (de) Supplementierte verdichtungsmittel für gewebe, methoden für ihre herstellung und ihre verwendung
DE60020526D1 (de) Osteogene pastenzusammensetzungen und ihre verwendung
NO20002357L (no) Fibrin-tetningsmidler eller -ad-hesiver inneholdende et hyaluronsyrederivat-materiale
WO2004034890A3 (en) Biological scaffolding material
WO2003013342A3 (en) Materials and methods for improved bone tendon bone transplantation
DK1715900T3 (da) Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
EP4125715A4 (en) IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE USING ABSORBABLE MATERIAL SCAFFOLDS
ATE227589T1 (de) Dreidimensionale biomaterialien, frei von zellulären komponenten und produkten, enthaltend hyaluronsäure-derivate, für die in-vivo regeneration von gewebezellen
DK0463126T3 (da) Fremgangsmåder til fremme af sårheling og genopretning af væv
DE69328100D1 (de) Biodegradierbare führungskanäle zur verwendung als chirurgische hilfsmittel in gewebewiederherstellung
EP0380370A3 (en) Inhibiting tumour recurrence after surgical resection